Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Whitham

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Neuroscience Research|October 10, 2001
Diminished frequency of interleukin-10-secreting, T-cell receptor peptide-reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV geneA A Vandenbark, T Finn, D Barnes, et al.
International Immunology|December 23, 1999
Differential susceptibility of human T(h)1 versus T(h) 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cellsA A Vandenbark, D Barnes, T Finn, et al.
Journal of Neuroscience Research|September 15, 1996
MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cellsY K Chou, A D Weinberg, A Buenafe, et al.
Archives of Neurology|June 1, 1997
Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosisP W Nance, W A Sheremata, S G Lynch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosisD N Bourdette, E Edmonds, C Smith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 21, 2010
Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trialJ F Lovera, E Frohman, T R Brown, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Neuroscience Research|October 10, 2001
Diminished frequency of interleukin-10-secreting, T-cell receptor peptide-reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV geneA A Vandenbark, T Finn, D Barnes, et al.
International Immunology|December 23, 1999
Differential susceptibility of human T(h)1 versus T(h) 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cellsA A Vandenbark, D Barnes, T Finn, et al.
Journal of Neuroscience Research|September 15, 1996
MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cellsY K Chou, A D Weinberg, A Buenafe, et al.
Archives of Neurology|June 1, 1997
Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosisP W Nance, W A Sheremata, S G Lynch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosisD N Bourdette, E Edmonds, C Smith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 21, 2010
Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trialJ F Lovera, E Frohman, T R Brown, et al.
Pageof 3